Form 4 for PCVX Vaxcyte, Inc.
Accepted 2024-01-31 00:00:00 ET · period of report 2024-01-29 · accession 0001415889-24-002055 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-31 | 2024-01-29 | PCVX | PICKERING GRANT | CEO, Dir | S - Sale+OE | $66.03 | -30.0K | 375.8K | -7% | -$1.98M |
| D | 2024-01-31 | 2024-01-29 | PCVX | PICKERING GRANT | CEO, Dir | M - OptEx | $1.79 | +30.0K | 405.8K | +8% | +$53.7K |
| D | 2024-01-31 | 2024-01-29 | PCVX | PICKERING GRANT | CEO, Dir | M - OptEx | $0.00 | -30.0K | 75.2K | -29% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-29 | S | D | 30,000 | $66.03 | 375,814 | D | — | — | |
| 2 | Common | Common Stock | 2024-01-29 | M | A | 30,000 | $1.79 | 405,814 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-01-29 | M | D | 30,000 | $0.00 | 75,225 | D | $1.79 · — to 2027-05-17 | 30,000 Common Stock | (F4) Stock Option is fully vested and exercisable. |